HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
2014 · The Lancet · 704 citations
https://doi.org/10.1016/s0140-6736(14)61183-1
A
Anthonius de Boer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
498
Papers
20.8K
Citations
70
h-index
302
i10-index
Anthonius de Boer is an academic researcher from Utrecht University. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Pharmacogenetics and Drug Metabolism & Pharmaceutical Economics and Policy. The author has an h-index of 70, co-authored 424 publications.
ORCID: 0000-0002-9485-8037Papers by this author
worksWhat Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
2017 · Value in Health · 347 citations
https://doi.org/10.1016/j.jval.2017.03.008
Comparison of different pain scoring systems in critically ill patients in a general ICU
2008 · Critical Care · 209 citations
https://doi.org/10.1186/cc6789
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height
2010 · The American Journal of Human Genetics · 132 citations
https://doi.org/10.1016/j.ajhg.2010.11.007
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
2012 · The Lancet · 118 citations
https://doi.org/10.1016/s0140-6736(12)60312-2
Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
2017 · PharmacoEconomics · 96 citations
https://doi.org/10.1007/s40273-017-0596-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat